ARDELYX INC. - COMMON STOCK

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines

17 Jul 2024 17:10:43 By Nasdaq GlobeNewswire

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

02 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

28 Jun 2024 08:17:59 By Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

30 May 2024 16:02:00 By Nasdaq GlobeNewswire

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

22 May 2024 08:02:00 By Nasdaq GlobeNewswire

Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

21 May 2024 08:02:21 By Nasdaq GlobeNewswire

Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)

16 May 2024 08:01:41 By Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

14 May 2024 16:02:00 By Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference

07 May 2024 08:01:45 By Nasdaq GlobeNewswire

Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update

02 May 2024 16:02:28 By Nasdaq GlobeNewswire

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings

01 May 2024 08:00:01 By Nasdaq GlobeNewswire

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024

18 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

28 Mar 2024 16:05:00 By Nasdaq GlobeNewswire

Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy

25 Mar 2024 08:00:00 By Nasdaq GlobeNewswire

Ardelyx, Inc. Reports Employment Inducement Grants

12 Mar 2024 16:35:00 By Nasdaq GlobeNewswire

Ardelyx to Participate at the Cowen 44th Annual Health Care Conference

27 Feb 2024 08:00:22 By Nasdaq GlobeNewswire

Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

22 Feb 2024 16:01:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

12 Feb 2024 09:45:08 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

09 Feb 2024 09:46:16 By NetDania Notify

NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK

08 Feb 2024 09:54:40 By NetDania Notify